Ontario Pharmacists' Association disappointed with government's regulatory changes

NewsGuard 100/100 Score

The Ontario Pharmacists' Association today expressed concerns and disappointment with the Ontario government's announcement that it is moving ahead with regulatory changes that will significantly reduce support to Ontario pharmacists and their patients.

On Monday, June 7, the government announced it has finalized plans to lower generic drug prices and eliminate professional allowances, while reinvesting some money in pharmacists' services. The changes are to start taking effect July 1.

"We are extremely disappointed that the government did not choose to invest more in pharmacy, or provide the support to help pharmacists deal with these unprecedented changes to funding," said Dean Miller, Chair of the Board of the Ontario Pharmacists' Association. "What the government is providing in return is clearly insufficient, and more investment is necessary to help pharmacists deliver the care that patients need."

Miller said pharmacists will be forced to make some difficult choices as they evaluate the level of care they will be able to provide moving forward. There are concerns that patients may experience reductions in clinic services and pharmacy hours, and direct access to pharmacists may be limited.

"These changes will affect everyone in community pharmacy - owners and staff alike - but will be particularly hard on independent pharmacists and their patients," Miller said.

The Ontario Pharmacists' Association will continue to press the government to provide more support for uninsured pharmacy services - those that pharmacists provide today, as well as the new services that will be possible under Bill 179's increased professional scope of practice.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Comparing HIV PrEP medications: Study explores hypertension risk in adults on TAF vs. TDF